Hain Celestial Misses Oct 12 Lender Deadline for $323M AURELIUS Sale; Board Reshuffled
HAIN is trading near its 52-week low of $0.48 (13% above the low) on light trading volume (0.2× avg).
Summary
Hain Celestial disclosed that the lender amendment required by October 12 to close its $323M International business sale to AURELIUS was not satisfied, leaving the deal and its $305–310M of expected net proceeds in limbo while $558M of debt matures in December 2026. The board also turned over, with two directors resigning and two new ones appointed.
Key Events · M&A and Partnerships · HAIN
-
Lender Deadline Missed for AURELIUS Sale
The credit-agreement amendment condition required by October 12, 2026 for the $323M International business sale to AURELIUS was not satisfied; the company says it continues discussions with AURELIUS and its lenders.
-
Deleveraging Plan at Risk
The deal was expected to deliver $305–310M of net proceeds to reduce debt, against $558M due in December 2026 and an auditor going-concern warning in the FY2026 10-K.
-
Board Overhaul Announced
Shervin Korangy and Carlyn Taylor resigned October 9, 2026; Patricia Ferrari and Richard Shinder were appointed October 11, 2026, each receiving a $30,000 monthly cash fee.
-
Nasdaq Listing Clock Running
The company transferred to the Nasdaq Capital Market on September 28, 2026 with a 180-day extension to March 22, 2027 to regain compliance.
Analysis · HAIN · Manufacturing
The $323M sale of Hain's International business to AURELIUS was the centerpiece of its plan to pay down the $558M of debt due December 2026 that triggered the going-concern warning in the FY2026 10-K. The deal's closing condition — a lender amendment to the credit agreement by October 12, 2026 — was not met. The company says it is still talking to AURELIUS and its lenders and evaluating all paths, but the missed deadline removes the near-term certainty of the $305–310M of net proceeds that were supposed to reduce that debt. Separately, two directors resigned October 9 and two were appointed October 11 at $30,000/month each, a board overhaul that lands while the capital structure is unresolved. With the stock at $0.54 and the company already on the Nasdaq Capital Market under a 180-day extension to March 22, 2027, the failed condition is a direct threat to the deleveraging plan and raises the odds of a distressed refinancing or worse.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 46.5% of the 301 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.48%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HAIN was trading at $0.54 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $52.5M. The 52-week trading range was $0.48 to $1.64. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.